These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19946342)

  • 21. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
    Gasch O; Fernández N; Ayats J; Santin M
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
    Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
    Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catheter-associated aspergillosis of the chest wall following allogeneic hematopoietic stem cell transplantation.
    Kerl K; Koch B; Fegeler W; Rossig C; Ehlert K; Groll AH
    Transpl Infect Dis; 2011 Apr; 13(2):182-5. PubMed ID: 20738831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients.
    Veroux M; Corona D; Gagliano M; Sorbello M; Macarone M; Cutuli M; Giuffrida G; Morello G; Paratore A; Veroux P
    Transplant Proc; 2007; 39(6):1838-40. PubMed ID: 17692627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole.
    Gubler C; Wildi SM; Imhof A; Schneemann M; Müllhaupt B
    Infection; 2007 Oct; 35(5):364-6. PubMed ID: 17721739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
    Chirch L; Roche P; Fuhrer J
    Ear Nose Throat J; 2008 Jan; 87(1):30-3. PubMed ID: 18357943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and interactions of new antifungals in stem cell transplant recipients.
    Girmenia C; Iori AP
    Expert Opin Drug Saf; 2012 Sep; 11(5):803-18. PubMed ID: 22913714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
    Stratakos G; Zakynthinos S
    Respiration; 2007; 74(6):609-10. PubMed ID: 18037812
    [No Abstract]   [Full Text] [Related]  

  • 29. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
    Ullmann AJ
    Curr Med Res Opin; 2003; 19(4):263-71. PubMed ID: 12841918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment.
    Gregg KS; Kauffman CA
    Semin Respir Crit Care Med; 2015 Oct; 36(5):662-72. PubMed ID: 26398533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
    Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
    Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in Germany.
    Jansen JP; Kern WV; Cornely OA; Karthaus M; Ruhnke M; Ullmann AJ; Resch A
    Value Health; 2006; 9(1):12-23. PubMed ID: 16441520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
    Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
    J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CNS-aspergillosis: are there new treatment options?
    Schwartz S; Thiel E
    Mycoses; 2003; 46 Suppl 2():8-14. PubMed ID: 15055138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
    Tsiodras S; Zafiropoulou R; Giotakis J; Imbrios G; Antoniades A; Manesis EK
    Transpl Infect Dis; 2004 Mar; 6(1):37-40. PubMed ID: 15225226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.
    Herbrecht R; Maertens J; Baila L; Aoun M; Heinz W; Martino R; Schwartz S; Ullmann AJ; Meert L; Paesmans M; Marchetti O; Akan H; Ameye L; Shivaprakash M; Viscoli C
    Bone Marrow Transplant; 2010 Jul; 45(7):1227-33. PubMed ID: 20062093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.